IBDEI0UQ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15156,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15156,1,4,0)
 ;;=4^205.12
 ;;^UTILITY(U,$J,358.3,15156,1,5,0)
 ;;=5^CML,In Relapse
 ;;^UTILITY(U,$J,358.3,15156,2)
 ;;=^336471
 ;;^UTILITY(U,$J,358.3,15157,0)
 ;;=284.81^^89^902^14
 ;;^UTILITY(U,$J,358.3,15157,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15157,1,4,0)
 ;;=4^284.81
 ;;^UTILITY(U,$J,358.3,15157,1,5,0)
 ;;=5^Aplastic Anemia d/t Drugs
 ;;^UTILITY(U,$J,358.3,15157,2)
 ;;=^335245
 ;;^UTILITY(U,$J,358.3,15158,0)
 ;;=284.89^^89^902^13
 ;;^UTILITY(U,$J,358.3,15158,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15158,1,4,0)
 ;;=4^284.89
 ;;^UTILITY(U,$J,358.3,15158,1,5,0)
 ;;=5^Aplastic Anemia d/t Chronic Disease
 ;;^UTILITY(U,$J,358.3,15158,2)
 ;;=^87880
 ;;^UTILITY(U,$J,358.3,15159,0)
 ;;=289.84^^89^902^119
 ;;^UTILITY(U,$J,358.3,15159,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15159,1,4,0)
 ;;=4^289.84
 ;;^UTILITY(U,$J,358.3,15159,1,5,0)
 ;;=5^Thrombocytopenia,Heparin Induced
 ;;^UTILITY(U,$J,358.3,15159,2)
 ;;=^336542
 ;;^UTILITY(U,$J,358.3,15160,0)
 ;;=V10.91^^89^902^67
 ;;^UTILITY(U,$J,358.3,15160,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15160,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,15160,1,5,0)
 ;;=5^H/O Neuroendocrine CA Tumor
 ;;^UTILITY(U,$J,358.3,15160,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,15161,0)
 ;;=V10.91^^89^902^66
 ;;^UTILITY(U,$J,358.3,15161,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15161,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,15161,1,5,0)
 ;;=5^H/O Malignant Neoplasm,Unspec
 ;;^UTILITY(U,$J,358.3,15161,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,15162,0)
 ;;=465.9^^89^903^70
 ;;^UTILITY(U,$J,358.3,15162,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15162,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,15162,1,5,0)
 ;;=5^URI
 ;;^UTILITY(U,$J,358.3,15162,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,15163,0)
 ;;=462.^^89^903^61
 ;;^UTILITY(U,$J,358.3,15163,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15163,1,4,0)
 ;;=4^462.
 ;;^UTILITY(U,$J,358.3,15163,1,5,0)
 ;;=5^Sore Throat
 ;;^UTILITY(U,$J,358.3,15163,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,15164,0)
 ;;=466.0^^89^903^3
 ;;^UTILITY(U,$J,358.3,15164,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15164,1,4,0)
 ;;=4^466.0
 ;;^UTILITY(U,$J,358.3,15164,1,5,0)
 ;;=5^Bronchitis,Acute
 ;;^UTILITY(U,$J,358.3,15164,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,15165,0)
 ;;=112.1^^89^903^79
 ;;^UTILITY(U,$J,358.3,15165,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15165,1,4,0)
 ;;=4^112.1
 ;;^UTILITY(U,$J,358.3,15165,1,5,0)
 ;;=5^Vulvovaginitis,Candidal
 ;;^UTILITY(U,$J,358.3,15165,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,15166,0)
 ;;=616.0^^89^903^13
 ;;^UTILITY(U,$J,358.3,15166,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15166,1,4,0)
 ;;=4^616.0
 ;;^UTILITY(U,$J,358.3,15166,1,5,0)
 ;;=5^Cervicitis
 ;;^UTILITY(U,$J,358.3,15166,2)
 ;;=^21925
 ;;^UTILITY(U,$J,358.3,15167,0)
 ;;=599.0^^89^903^71
 ;;^UTILITY(U,$J,358.3,15167,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15167,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,15167,1,5,0)
 ;;=5^UTI
 ;;^UTILITY(U,$J,358.3,15167,2)
 ;;=UTI^124436
 ;;^UTILITY(U,$J,358.3,15168,0)
 ;;=460.^^89^903^45
 ;;^UTILITY(U,$J,358.3,15168,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15168,1,4,0)
 ;;=4^460.
 ;;^UTILITY(U,$J,358.3,15168,1,5,0)
 ;;=5^Nasopharyngitis, Acute
 ;;^UTILITY(U,$J,358.3,15168,2)
 ;;=^26543
 ;;^UTILITY(U,$J,358.3,15169,0)
 ;;=372.30^^89^903^14
 ;;^UTILITY(U,$J,358.3,15169,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15169,1,4,0)
 ;;=4^372.30
 ;;^UTILITY(U,$J,358.3,15169,1,5,0)
 ;;=5^Conjunctivitis
 ;;^UTILITY(U,$J,358.3,15169,2)
 ;;=^27546
